Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

17 Nov 2008 07:00

RNS Number : 2502I
Kingspan Group PLC
17 November 2008
 

Kingspan Group plc

Interim Management Statement

17 November 2008 

Kingspan Group plc, the leading manufacturer of sustainable building solutions, today issues its Interim Management Statement for the period 1 July 2008 to the date of this announcement.

The Interim Results announcement on 27 August 2008 noted that the contraction in construction markets and rising raw material prices would present challenges in the second half of the year for the Group. This has transpired, particularly through September and October, when the effects of the contraction in the global economic environment became more evident. This has resulted in further reductions in construction activity, particularly in the UK and Ireland. Residential construction in these markets has remained weak, and activity in the commercial sector has slowed markedly during the period. This trend has been caused largely by the significant tightening of development funding and a sharp reduction in consumer confidence. In contrast to this, activity in the commercial and industrial sectors in Western and Central Europe remained robust. The sectors which Kingspan serves in North America also displayed more resilience than other sectors in the period.

Across the Group, sales are down 9% in the ten months to 31 October compared to the same period prior year, but are down only 3% on a constant currency basis.

Insulated Panel sales revenues were down about 6% in the first ten months on a constant currency basis. Of this, the UK and Ireland were down 16% compensated by increases in Western, Central and Eastern Europe. Volume order intake for insulated panels shows a year on year decline of 4%, with the UK and Ireland down 19% compensated by increases in other regions. This reflects a recent further slowdown in the UK and Ireland, and some tempering of activity in Western, Central and Eastern Europe since the Interim Results.

Insulation Board sales revenues were down approximately 4% in the first ten months on a constant currency basis with volumes down 9%. This volume decline was partially compensated by increased selling prices and improved value mix. While insulation boards are making steady progress in Western and Central Europe, this was not enough to off-set the effects of the significant decline in construction in the main UK and Irish markets in the period 

Across the other product areas in the ten month period, on a constant currency basis, Environmental & Renewables sales were up 4%, Access Floors up 11%, and Offsite/Structural Products down 16%. 

Raw material prices rose sharply through the first nine months of the year but have eased somewhat in October. A weakening market has resulted in a time lag in passing these cost increases on to the market which has resulted in lower margins. Margins have also been negatively impacted by increased transport costs and by reduced operational leverage due to the fall off in volume in certain areas. On the positive side, current indications are that steel prices will reduce further in the early part of 2009, chemical prices are expected to remain reasonably stable and transport costs should also reduce.

Against this backdrop the Group now expects to report a full year percentage decline in operating profits before exceptionals of approximately 33%.  

In the light of reduced forecasts for the year ahead, a number of the Group's businesses have been undergoing a restructuring process which will be substantially completed by year end. Non-recurring exceptional items related to restructuring and related costs will impact the result for the current year by approximately €25 million.   

Financial Position and Other Developments

On the 22 August the Group acquired Metecno Inc., the second largest insulated panel producer in the US, for a total consideration of $111 million.

Under the share buyback programme, circa 2.1 million shares were purchased since the 30 June for a consideration of approximately €12.5 million. This gives a total share buyback since the start of the programme of 5,237,017 shares or 3.06% of the ordinary shares in issue.

On 30 September the Group completed a five year syndicated revolving credit facility for €330 million with its bankers. At 31 October the Group had total facilities of €580 million. Net debt at 31 October was approximately €330 million. The increase in debt reflects the continued capital expenditure in new capacity mainly in Continental Europe and North America, albeit at a slower pace than anticipated.

Looking Ahead

Medium term, the Group remains confident that both its product and geographic strategy, together with its positioning at the heart of low energy building technologies will leave it well poised to take full advantage of renewed market opportunity once economic growth resumes. Additionally, Kingspan's ability to continue to invest in the future development of the business is underpinned by a strong balance sheet that has been reinforced by the recent €330 million refinancing of its five year facilities. In the short term, management are continuing to take significant actions and initiatives to reduce costs in anticipation of the fact that 2009 is almost certain to provide even tougher challenges than those encountered in the current year.

For further information contact:

Murray Consultants

Tel: +353 (0) 1 4980300

Ed Micheau

Buchanan Communications 

Tel: +44 207 466 5000

Tim Thompson/Jeremy Garcia

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDGBDBGSBGGIL
Date   Source Headline
7th Mar 20173:57 pmRNSAnnual Financial Report
6th Mar 20177:00 amRNSMain Securities Market Notice
1st Mar 20175:38 pmRNSDirector/PDMR Shareholding
1st Mar 20179:49 amRNSDirector/PDMR Shareholding
1st Mar 20179:30 amRNSTotal Voting Rights
27th Feb 20174:32 pmRNSDirector/PDMR Shareholding
23rd Feb 201710:20 amRNSBlock Listing Application
22nd Feb 20173:04 pmRNSDirector/PDMR Shareholding
20th Feb 20174:36 pmRNSDirector/PDMR Shareholding
20th Feb 201712:32 pmRNSDirector/PDMR Shareholding
17th Feb 20171:51 pmRNSHolding(s) in Company
17th Feb 20177:00 amRNSFinal Results
24th Jan 201712:04 pmRNSNotice of Results
18th Jan 201711:19 amRNSHolding(s) in Company
3rd Jan 20179:45 amRNSHolding(s) in Company
3rd Jan 20179:30 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSTotal Voting Rights
14th Dec 20165:02 pmRNSHolding(s) in Company
12th Dec 20164:09 pmRNSHolding(s) in Company
1st Dec 20162:28 pmRNSTotal Voting Rights
29th Nov 20162:30 pmRNSHolding(s) in Company
23rd Nov 20165:04 pmRNSHolding(s) in Company
21st Nov 20162:33 pmRNSDirector/PDMR Shareholding
16th Nov 20165:07 pmRNSCompletion of US private placement
16th Nov 20162:44 pmRNSHolding(s) in Company
14th Nov 20167:00 amRNSTrading Update
10th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 201611:08 amRNSHolding(s) in Company
1st Nov 20161:15 pmRNSTotal Voting Rights
21st Oct 201612:46 pmRNSHolding(s) in Company
3rd Oct 20161:27 pmRNSTotal Voting Rights
26th Sep 201610:01 amRNSHolding(s) in Company
1st Sep 20163:39 pmRNSDirector/PDMR Shareholding
1st Sep 201611:00 amRNSTotal Voting Rights
25th Aug 20164:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20167:00 amRNSHalf-year Report
2nd Aug 201610:10 amRNSHolding(s) in Company
27th Jul 20165:39 pmRNSHolding(s) in Company
25th Jul 20165:09 pmRNSHolding(s) in Company
14th Jul 20162:18 pmRNSHolding(s) in Company
1st Jul 20164:43 pmRNSHolding(s) in Company
1st Jul 20169:15 amRNSBlock listing Interim Review
1st Jul 20169:00 amRNSTotal Voting Rights
28th Jun 201610:21 amRNSHolding(s) in Company
10th Jun 20163:15 pmRNSHolding(s) in Company
1st Jun 20169:57 amRNSTotal Voting Rights
24th May 20165:02 pmRNSDirector/PDMR Shareholding
20th May 20164:28 pmRNSDirector/PDMR Shareholding
19th May 20164:25 pmRNSDirector/PDMR Shareholding
12th May 20162:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.